Member Login:

| Login Help
Home  |  Contact Us  |  Site Map
| MENU | ITSCC: International Transplant Skin Cancer Collaborative

Skin Cancer in Organ Transplant Recipients

Prevention and early detection of skin cancer is of the utmost importance.

Organ transplant recipients are at increased risk of developing skin cancer compared to the general population. The immunosuppressive medications that allow the transplanted organ to function and survive also increase the risk of skin cancer. Most skin cancer is easily cured if recognized and treated early. Most transplant recipients will have few skin cancers; however, a few will have hundreds of skin cancers. For patients with many skin cancers, the extensive and repeated treatments may result in significant tissue loss and scarring, sometimes effecting appearance and the ability to function normally. The occurrence of skin cancer can decrease the quality of life for organ recipients. Aggressive skin cancers can potentially lead to death. Skin cancer may be a preventable disease, so efforts should be made to prevent it. If skin cancer does occur, early identification and treatment is very important.



Updated on Friday, June 22nd, 2012

ITSCC

March 20, 2014
5:00 - 9:00 pm
ITSCC Annual Membership and Business Meeting
Denver, CO
Registration required ($25)


March 21, 2014
9:00 - 11:00 am
ITSCC Board of Directors Meeting
Denver, CO


May 15-18, 2014
SCOPE Annual Meeting
Leiden, The Netherlands
RSVP


October 16-19, 2014
Biennial Retreat
Essex, MA


Survey Request
We are looking at funding opportunities for a transplant skin cancer registry. A knowledge of which transplant centers are associated with our members and a rough idea of how many transplant patients are being followed would be helpful in this process. Please provide us with these brief details regarding your transplant practice. Click here to take survey